Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate

Cancer Science

Volumn 95, Issue 6, 2004, Pages 491-495

  Tian, Wei ^a   Osawa, Motoki ^a   Horiuchi, Hidekazu ^a   Tomita, Yoshihiko ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROSS CYSTIC DISEASE FLUID PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROLACTIN INDUCIBLE PROTEIN; SECRETORY PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL VESICLE;

ADENOCARCINOMA; AGED; ANIMALS; APOLIPOPROTEINS; APOLIPOPROTEINS D; CARRIER PROTEINS; EPITHELIUM; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042547420     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03238.x     Document Type: Article

References (30)

1. Haagensen DE, Mazoujian G. In: Haagensen DE, editor. Diseases of the breast. Philadelphia: WB Saunders Co; 1986. p. 474-500
2. Murphy LC, Tsuyuki D, Myal Y, Shiu RPC. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D. J Biol Chem 1987; 262: 15236-41.
3. Autiero M, Abrescia P, Guardiola J. Interaction of seminal plasma proteins with cell surface antigens: presence of a CD4-binding glycoprotein in human seminal plasma. Exp Cell Res 1991; 197: 268-71.
4. Caputo E, Autiero M, Mani JC, Basmociogullari S, Piatier-Tonneau D, Guardiola J. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia. Int J Cancer 1998; 78: 76-85.
5. Dumont M, Dauvois S, Simard J, Garcia T, Schachter B, Labrie F. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J Steroid Biochem 1989; 34: 397-402.
6. Carsol JL, Gingras S, Simard J. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol Endocrinol 2002; 16: 1696-710.
7. Gaubin M, Autiero M, Basmaciogullari S, Métivier D, Misëhal Z, Culerrier R, Oudin A, Guardiola J, Piatier-Tonneau D. Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells. J Immunol 1999; 162: 2631-8.
8. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alphalactalbumin. Hum Pathol 1989; 20: 281-7.
9. Monteagudo C, Merino MJ, LaPorte N, Neumann RD. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum Pathol 1991; 22: 368-72.
10. Clark JW, Snell L, Shiu RP, Orr FW, Maitre N, Vary CP, Cole DJ, Watson PH. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer 1999; 81: 1002-8.
11. Osawa M, Seto Y, Yukawa N, Saito T, Takeichi S. A 20-kDa protein in human seminal plasma that is identical to gross cystic disease fluid protein 15 and prolactin-inducible protein. Arch Androl 1996; 36: 29-39.
12. Viacava P, Naccarato AG, Bevilacqua. G. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues. Virchows Arch 1998; 432: 255-60.
13. Murphy LC, Lee-Wing M, Goldenberg GJ, Shiu RP. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res 1987; 47: 4160-4.
14. Satoh F, Umemura S, Osamura RY. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Breast Cancer 2000; 7: 49-55.
15. Hall RE, Clements JA, Birrell SN, Tilley WD. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer 1998; 78: 360-5.
16. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23: 273-9.
17. Lundwall A, Bjartell A, Olsson AY, Malm J. Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues. Mol Hum Reprod 2002; 8: 805-10.
18. Schenkels LC, Walgreen-Weterings E, Oomen LC, Bolscher JG, Veerman EC, Nieuw Amerongen AV. In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species. Biol Chem 1997; 378: 83-8.
19. Bergamo P, Balestrieri M, Cammarota G, Guardiola J, Abrescia P. CD4-mediated anchoring of the seminal antigen gp17 onto the spermatozoon surface. Hum Immunol 1997; 58: 30-41.
20. Huang YH, Chu ST, Chen YH. Seminal vesicle autoantigen, a novel phospholipid-binding protein secreted from luminal epithelium of mouse seminal vesicle, exhibits the ability to suppress mouse sperm motility. Biochem J 1999; 343: 241-8.
21. Osawa M, Horiuchi H, Tian W, Kaneko M. Divergent evolution of the prolactin-inducible protein gene and related genes in the mouse genome. Gene 2004; 325: 179-86.
22. Caputo E, Camarca A, Moharram R, Tornatore P, Thatcher B, Guardiola J, Martin BM. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach. Biochemistry 2003; 42: 6169-78.
23. Zenklusen JC, Bieche I, Lidereau R, Conti CJ. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 1994; 91: 12155-8.
24. Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res 1995; 1: 1385-9.
25. Autiero M, Culerrier R, Bouchier C, Basmaciogullari S, Gaubin M, El Marhomy S, Blanchet P, Paradis V, Jardin A, Guardiola J, Piatier-Tonneau D. Abnormal restriction pattern of PIP gene associated with human primary prostate cancers. DNA Cell Biol 1999; 18: 481-7.
26. Autiero, M, Camarca A, Ciullo M, Debily MA, El Marhomy S, Pasquinelli R, Capasso I, D'Aiuto G, Anzisi AM, Piatier-Tonneau D, Guardiola J. Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas. Int J Cancer 2002; 99: 370-7.
27. Ciullo M, Debily MA, Rozier L, Autiero, M, Billault A, Mayau V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, Piatier-Tonneau D, Debatisse M. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 2002; 11: 2887-94.
28. Jones C, Damiani S, Wells D, Chaggar R, Lakhani SR, Eusebi V. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 2001; 158: 207-14.
29. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9: 401-6.
30. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001; 61: 3550-5.